SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-24-000018
Filing Date
2024-05-06
Accepted
2024-05-06 08:04:25
Documents
15
Period of Report
2024-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krys-20240506.htm   iXBRL 8-K 33690
2 EX-99.1 exhibit9912024-1q24pr.htm EX-99.1 86826
6 image_0.jpg GRAPHIC 187260
  Complete submission text file 0001711279-24-000018.txt   497024

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20240506.xsd EX-101.SCH 1910
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20240506_lab.xml EX-101.LAB 20073
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20240506_pre.xml EX-101.PRE 11516
18 EXTRACTED XBRL INSTANCE DOCUMENT krys-20240506_htm.xml XML 2537
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 24915639
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)